ProAmatine (midodrine)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved September 1996

Specific Treatments:


Find Related Trials for The Following Conditions

General Information

ProAmatine has been approved for the treatment of hypotension.

Additional Information

Hypotension is a low blood pressure condition characterized by a sudden drop in blood pressure upon assuming an upright posture. The condition is often accompanied by dizziness, lightheadedness, and fainting, which in older patients often leads to traumatic injury associated with falls.